These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8105765

  • 1. Pros and cons of over-the-counter availability of histamine2-receptor antagonists.
    Feldman M.
    Arch Intern Med; 1993 Nov 08; 153(21):2415-24. PubMed ID: 8105765
    [No Abstract] [Full Text] [Related]

  • 2. Over-the-counter H2-receptor antagonists for heartburn.
    Med Lett Drugs Ther; 1995 Oct 27; 37(960):95-6. PubMed ID: 7565298
    [No Abstract] [Full Text] [Related]

  • 3. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC, Bohn RL, Avorn J.
    Med Care; 1997 Jan 27; 35(1):32-48. PubMed ID: 8998201
    [Abstract] [Full Text] [Related]

  • 4. Over the counter H2 receptor antagonists. Increase the risks to offshore workers.
    Cooper JR.
    BMJ; 1994 Oct 29; 309(6962):1156-7. PubMed ID: 7987116
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety implications of the over-the-counter availability of H2-antagonists.
    Andersen M, Schou JS.
    Drug Saf; 1993 Mar 29; 8(3):179-85. PubMed ID: 8095787
    [No Abstract] [Full Text] [Related]

  • 8. [Over-the-counter drugs, subsidy and safety].
    Kampmann JP.
    Ugeskr Laeger; 1991 May 13; 153(20):1401-2. PubMed ID: 1674178
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Consumer usage patterns of nonprescription histamine2-receptor antagonists.
    Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S.
    Am J Gastroenterol; 2004 Apr 13; 99(4):606-10. PubMed ID: 15089889
    [Abstract] [Full Text] [Related]

  • 13. Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.
    Tasch RF, Goeree R, Henke CJ, O'Brien BJ.
    Pharmacoeconomics; 1996 Jan 13; 9(1):61-75. PubMed ID: 10160088
    [Abstract] [Full Text] [Related]

  • 14. The effect on social welfare of a switch of second-generation antihistamines from prescription to over-the-counter status: a microeconomic analysis.
    Shih YC, Prasad M, Luce BR.
    Clin Ther; 2002 Apr 13; 24(4):701-16. PubMed ID: 12017413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.
    Hunt RH.
    CMAJ; 1996 Jan 01; 154(1):49-53. PubMed ID: 8542566
    [Abstract] [Full Text] [Related]

  • 18. Side effects of histamine2-receptor antagonists.
    McGuigan JE.
    Clin Gastroenterol; 1983 Sep 01; 12(3):819-38. PubMed ID: 6137301
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.